EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

Gossec, Laure; Kerschbaumer, Andreas; J O Ferreira, Ricardo; Aletaha, Daniel; Baraliakos, Xenofon; Bertheussen, Heidi; Boehncke, Wolf‐­Henning; Appel Esbensen, Bente; B. McInnes, Iain; McGonagle, Dennis; Winthrop, Kevin; Bălănescu, Andra; Bálint, P; R Burmester, Gerd; D. Cañete, Juan; Claudepierre, Pascal; Eder, Lihi; Lund Hetland, Merete; Iagnocco, Annamaria; Erik Kristensen, Lars; Lories, Rik; Queiró, Rubén; Mauro, Daniele; Marzo‐Ortega, Helena; J. Mease, Philip; Nash, Peter; Wagenaar, Wendy; Savage, L.; Schett, Georg; Shoop-Worrall, Stephanie; Tanaka, Yoshiya; Van den Bosch, Filip; H M van der Helm–van Mil, Annette; Zabotti, Alen; van der Heijde, Désirée; S Smolen, Josef

doi:10.1136/ard-2024-225531

Public

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

Published in Annals of the Rheumatic Diseases • Mar 18, 2024

Authors:

Laure Gossec

Andreas Kerschbaumer

Ricardo J O Ferreira

Abstract

OBJECTIVE: New modes of action and more data on the efficacy and safety of existing drugs in psoriatic arthritis (PsA) required an update of the EULAR 2019 recommendations for the pharmacological treatment of PsA. METHODS: Following EULAR standardised operating procedures, the process included a sys...

Subject

Medicine

Psoriatic arthritis

Arthritis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!